Pharmalot…Pharmalittle…
Make a commentBy Ed Silverman // June 15th, 2007 // 8:19 pm
And so another exciting week comes to a close. Diet pills dominated the news, but as always, safety concerns lingered as Congress debated PDUFA and Avandiagate was hashed over still more. Now, though, the time has come for a brief respite to catch up on yardwork, tidy up around the castle and spend time with the heirs. For those of you who require a gentle reminder, pick up the phone on Sunday to say hello to you-know-who. Meanwhile, we leave you with these….
Gilead’s Blood Pressure Drug Is Approved (Yahoo/AP)
PhRMA Hires The Roth Group For Lobbying (The Houston Chronicle/AP)
Aegerion Pharmaceuticals Postpones IPO (Biospace.com)
House Committee Seeks Info From Amgen, J&J (Bloomberg News)
Takeda Spends More Than It Makes On Rozerem (The Chicago Tribune)
IMS Health Is Strengthened By NH Ruling (BusinessWeek)